EdwardWVeillonMD

Maternal & Fetal Medicine/High Risk

Physician

Dr. Veillon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Mississippi Medical CenterFellowship, Maternal-Fetal Medicine, 2006 - 2009
University of Mississippi Medical CenterResidency, Obstetrics and Gynecology, 2002 - 2006
LSU School of Medicine in ShreveportClass of 2002

Effectiveness of CGMS vs. Self-monitoring Blood Glucose (SMBG) in Woman With Gestational Diabetes Start of enrollment: 2021 Oct 01
Active, not recruiting
Not Applicable
Roles: Contact
The CGMS in GDM Labor and Delivery Study Start of enrollment: 2021 Nov 01
Completed
Not Applicable
Roles: Principal Investigator, Contact
The PPCGMS Intervention After GDM Trial Start of enrollment: 2024 Feb 06
Recruiting
Not Applicable
Roles: Contact

PubMed

36 citations
Effects of 17-Hydroxyprogesterone on Tumor Necrosis Factor-α-Induced Hypertension During Pregnancy
Sharon D. Keiser, Edward Veillon, Marc Parrish, William A. Bennett, Kathy Cockrell
American Journal of Hypertension. 2009-10-01
45 citations
Progesterone does not prevent preterm births in women with twins.
Christian M. Briery, Edward Veillon, Chad K. Klauser, Rick W. Martin, Suneet P. Chauhan
Southern Medical Journal. 2009-09-01
37 citations
Women with preterm premature rupture of the membranes do not benefit from weekly progesterone
Christian M. Briery, Edward Veillon, Chad K. Klauser, Rick W. Martin, Everett F. Magann
American Journal of Obstetrics and Gynecology. 2011-01-01